ABCG2 and neoplasm: In terms of mechanistic studies, it has been found that ABC transporters affect tumor drug resistance through multiple signaling pathways, such as PI3K/Akt [10], NF-κB [11], Nrf2 [12], Wnt/β-catenin [13], JNK [14].